Embolization Agents Market Trends and Analysis by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Embolization Agents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Coils, Plugs, Beads/Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others)

  • Report Date : Oct 2021
  • Report Code : TIPRE00025058
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 219

The embolization agents market is projected to reach US$ 4,525.75 million by 2028 from US$ 2,714.82 million in 2021; it is expected to grow at a CAGR of 7.6% from 2021 to 2028.

The growth of the market is attributed to the rising incidence of tumors and aneurysms and growing prevalence of hypertension, obesity, smoking, and alcoholism. However, high costs of embolization agents restrain the embolization agents market growth. Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are mostly used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration required for arterial occlusion, embolization agents are classified as temporary or permanent.

In the US, the demand for warts treatment procedures has reduced due to the shift in the focus on COVID-19 treatment. The COVID-19 pandemic has been causing havoc in the global supply chains, consumer markets, and economies. This situation has led to a decline in cardiac procedures carried out in various countries in Asia Pacific. The measures implemented by governments across the world have negatively impacted the embolization agents market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Embolization Agents Market: Strategic Insights

embolization-agents-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights
Rising Incidence of Tumors and Aneurysms Fuels Embolization Agents Market Growth


According to the National Cancer Institute, in 2020, there were 1,806,590 new cancer cases and 606,520 deaths due to the disease in the US. In 2020, prostate, lung, and colorectal cancers accounted for 43 % of all cancers diagnosed in men. Breast, lung, and colorectal cancers are the three most frequent cancers diagnosed in women. As per the Brain Aneurysm Foundation, Statistics and Facts report, in the US, around 6.5 million people that is 1 in 50 people have an unruptured brain aneurysm. It has also mentioned that 20% of the total people diagnosed with a brain aneurysm have more than one aneurysm. It has further reported that, every year, around 30,000 people in the US suffer from a brain aneurysm rupture and a brain aneurysm rupture takes place every 18 minutes. Further, as per the NHS, every year in the UK, 1 in 12,500 people have a ruptured brain aneurysm in England. Additionally, as per the ‘Unruptured Intracranial Aneurysms Pathogenesis and Individualized Management’ report published in Deutsches Ärzteblatt International in 2020, around 2 million people (adults) in Germany have an unruptured intracranial aneurysm (IA). Embolization agents are used to acutely stop the flow in a blood vessel or vascular territory by the means of mechanical occlusion. Embolizing agents, such as embolic microspheres (beads), are used to restrict the vascular supply to tumors and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. Liquid embolic agents are used to prevent blood supply to aneurysm or tumor. Thus, the increasing prevalence of aneurysms and cancers is creating high demand for embolization agents.

Product-Based Insights

Based on product, the embolization agents market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, and others. The beads/particles segment holds the largest share of the market. However, the coil segment is anticipated to register the highest CAGR during 2021–2028. Coil Embolization is a catheter-based procedure that allows precise occlusion of abnormal blood flow in a blood vessel. The increasing number of cardiac surgeries is propelling the market growth of this segment.

Application - Based Insights

Based on application, the embolization agents market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. The oncology segment holds the largest share of the market and is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the embolization agents market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment holds the largest market share and is estimated to register the highest CAGR during the forecast period. The market growth for this segment is attributed to the increasing number of hospitals across the world and rapidly growing number of surgical procedures.

Companies operating in the embolization agents market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Embolization Agents Market Regional Insights

The regional trends and factors influencing the Embolization Agents Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Embolization Agents Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

embolization-agents-market-global-geography
  • Get the Regional Specific Data for Embolization Agents Market

Embolization Agents Market Report Scope

Report Attribute Details
Market size in 2021 US$ 2.71 Billion
Market Size by 2028 US$ 4.53 Billion
Global CAGR (2021 - 2028) 7.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Coils
  • Plugs
  • Beads/Particles
  • Detachable Balloons
  • Glue
  • Sponge
  • Liquid Embolics
  • Sclerosants
  • Precipitating Agents
By Application
  • Oncology
  • Neurology
  • Urology
  • Cardiology
  • Peripheral Vascular Diseases
By End User
  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic
  • Terumo Corporation
  • Cook Medical LLC
  • Boston Scientific Corporation
  • Abbott
  • Stryker Corporation
  • Penumbra, Inc.
  • Merit Medical Systems Inc.
  • DePuy Synthes

  • Embolization Agents Market Players Density: Understanding Its Impact on Business Dynamics

    The Embolization Agents Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Embolization Agents Market are:

    1. Medtronic
    2. Terumo Corporation
    3. Cook Medical LLC
    4. Boston Scientific Corporation
    5. Abbott

    Disclaimer: The companies listed above are not ranked in any particular order.


    embolization-agents-market-cagr

    • Get the Embolization Agents Market top key players overview

    Embolization Agents Market – by Product

    • Coils
      • Detachable Coils
      • Pushable Coils
    • Beads/ Particles
      • Spherical
      • Non-Spherical
    • Plugs
    • Detachable Balloons
    • Glue
    • Sponge
    • Liquid Embolics
    • Sclerosants
    • Precipitating Agents
    • Others

    Embolization Agents Market – by Application

    • Oncology
    • Neurology
    • Urology
    • Cardiology
    • Peripheral Vascular Diseases
    • Others

    Embolization Agents Market – by End User

    • Hospitals
    • Cardiac Centers
    • Ambulatory Surgical Centers
    • Others

    Embolization Agents Market– by Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East and Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • Medtronic
    • Terumo Corporation
    • Cook Medical LLC
    • Boston Scientific Corporation
    • Abbott
    • Stryker Corporation
    • Penumbra, Inc.
    • Merit Medical Systems Inc.
    • DePuy Synthes
    • KANEKA CORPORATION

    Frequently Asked Questions

    What are the driving factors for the embolization agents market across the globe?

    The factors that are driving growth of the market are rising incidence of tumors and aneurysms, and growing incidence of hypertension, obesity, smoking, and alcoholism.

    What are embolization agents?

    Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are most used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration of time that arterial occlusion is required, embolization agents are classified as temporary or permanent.

    Who are the developments carrying out by major players in the embolization agents market?

    Various companies have made organic growth strategies in the embolization agents market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Medtronic, Cook Medical LLC amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

    Which region is the fastest growing in the embolization agents market?

    Asia Pacific is expected to be the fastest growing region in the embolization agents market. The growth of the market in this region is primarily due to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period.

    Which segment is growing at the highest CAGR in the embolization agents market?

    The coil segment is growing at the highest CAGR owing to increasing number of cardiac surgeries.

    Which region is dominated the embolization agents market?

    North America dominates the global embolization agents market due to factors such as increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Embolization Agents Market

    1. Medtronic
    2. Terumo Corporation
    3. Cook Medical LLC
    4. Boston Scientific Corporation
    5. Abbott
    6. Stryker Corporation
    7. Penumbra, Inc.
    8. Merit Medical Systems Inc.
    9. DePuy Synthes
    10. KANEKA CORPORATION            
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo